Five market-makers back CME eurozone inflation futures

It’s the exchange’s second stab at an exchange-traded inflation futures product following the launch of a US contract in February 2004. Critics argue that contract exposes users to seasonal inflation volatility because of its use of the quarterly US consumer price index (CPI) measure. They also argue that the exchange should have got more than just one market-maker – Barclays Capital – on board before launching the contract.

The CME appears to have responded to these criticisms, both by adopting the annual HICP index as the reference for the futures and by getting five investment banks to commit to providing liquidity ahead of launch.

Robin Ross, managing director of CME interest rate products, said the eurozone inflation swap market “currently lacks short-term, inflation-linked instruments. Our market-makers will help build and maintain liquidity, ensuring that end users can leverage the hedging benefits this new contract brings to the global market”.

The CME HICP futures will represent inflation on a notional value of €1 million for 12 calendar months. As with CME Eurodollar futures contracts, they will be quoted as 100 minus the annual inflation rate in the 12-month period proceeding the contract month.

“The new HICP futures will provide a much needed market for trading short-term inflation expectations,” said Borut Miklavcic, Lehman Brothers’ head of European inflation trading. “The instrument will not only enable derivative users to hedge fixings risk, but will also allow for trading forwards on European inflation-linked bonds and could kick-start trading in inflation-linked bond options.”

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here